Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial-Reference-Cited by-同舟云学术

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

Published:2021-03 Issue:3 Volume:79 Page:413-418
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

de Feria Cardet Rafael E.,Hofman Michael S.,Segard Tatiana,Yim Jackie,Williams Scott,Francis Roslyn J.,Frydenberg Mark,Lawrentschuk Nathan,Murphy Declan G.,De Abreu Lourenco Richard

Funder

Prostate Cancer Foundation of Australia

Movember Foundation

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

2. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study;Hofman;Lancet,2020

3. 68Ga-somatostatin analogue PET-CT: analysis of costs and benefits in a public hospital setting;Segard;J Med Imaging Radiat Oncol,2018

4. The Australian Department of Health. MBS Online. Medicare benefits schedule. www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Home.

5. Australian Bureau of Statistics. Employee earnings and hours, Australia. Reference period May 2018. www.abs.gov.au/statistics/labour/earnings-and-work-hours/employee-earnings-and-hours-australia/latest-release#:∼:text=In%20May%202018%2C%20non%2Dmanagerial,cash%20earnings%20rate%20of%20%2439.10.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy;Diagnostics;2024-09-05

2. Enhancing Hepatocellular Carcinoma Therapy with DOX-Loaded SiO2 Nanoparticles via mTOR-TFEB Pathway Autophagic Flux Inhibition;2024-09-03

3. Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer;Seminars in Nuclear Medicine;2024-06

4. Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging;Journal of Gastrointestinal and Abdominal Radiology;2024-05

5. Optimizing PSMA scintigraphy for resource limited settings – a retrospective comparative study;Cancer Imaging;2024-04-01